Study of 4 Bone Turnover Markers in Patients With Multiple Myeloma Treated With Intravenous Bisphosphonate in Routine Care
Condition(s):Multiple MyelomaLast Updated:November 1, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:November 1, 2022Recruiting
Condition(s):OsteoporosisLast Updated:September 21, 2021Recruiting
Condition(s):Primary AldosteronismLast Updated:December 2, 2015Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:December 3, 2020Unknown status
Condition(s):Osteoporosis; Diabetes MellitusLast Updated:October 27, 2015Unknown status
Condition(s):OsteoporosisLast Updated:March 18, 2021Completed
Condition(s):HypoxiaLast Updated:February 13, 2024Not yet recruiting
Condition(s):Osteoporosis; OsteopeniaLast Updated:October 4, 2016Completed
Condition(s):Bone Turnover Rate Disorder; Calcium Metabolism DisordersLast Updated:January 25, 2022Completed
Condition(s):Down SyndromeLast Updated:December 7, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.